74 - Respiratory Viral Infections and Vaccines

Moderator(s)

• 

  Rama Thyagarajan, MD MPH FIDSA CIC (she/her/hers)

  Clinical Associate Professor
  Dell Seton Medical Center, Department of Internal Medicine, Dell Medical School, University of Texas at Austin
  Leander, TX, United States
• 

  Ashish Bhargava, MD (he/him/his)

  Associate Professor
  Department of Internal Medicine
  Wayne State University, Henry Ford St. John
  Detroit, MI, United States

Presentations:

• 1:45 PM - 1:57 PM US ET

  Durability of Antibody Response to RSV Vaccination in Immunocompromised Individuals
  

  Co-Author: Zeba Nauroz, BDS, MPH – Johns Hopkins

  Co-Author: Camille Hage, MD MPH – Johns Hopkins University

  Co-Author: Isabella Sengsouk, BS – Johns Hopkins University

  Co-Author: Prasanthy Balasubramanian, MS – Johns Hopkins

  Co-Author: Xori Green, BS – Johns Hopkins University

  Co-Author: Woudase Gallo, BA – Johns Hopkins

  Co-Author: Jiashu Xue, MS – Johns Hopkins University

  Co-Author: Maggie Chahoud, BS – Johns Hopkins University

  Co-Author: Aaron Tobian, PhD, MD – Johns Hopkins University

  Co-Author: William Werbel, MD PhD – Johns Hopkins University

  Presenting Author: Andrew H. Karaba, MD PhD (he/him/his) – Johns Hopkins University
• 2:09 PM - 2:21 PM US ET

  Progress towards an EBV vaccine: Results of a Phase I, First-In-Human EBV gp350 Ferritin Nanoparticle Vaccine Candidate adjuvanted with Matrix-M®
  

  Presenting Author: Jessica Durkee-Shock, MD MHSc – Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health

  Co-Author: Hanh Nguyen, BS – Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health

  Co-Author: Alexander C. Vostal, MD – Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health

  Co-Author: Sally Hunsberger, PhD – National Institute of Allergy and Infectious Diseases

  Co-Author: Megan C. Grieco, MSPH – National Institute of Allergy and Infectious Diseases

  Co-Author: Krista Gangler, RN – Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health

  Co-Author: Karenna Barton, BS – Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health

  Co-Author: Maria Ploussiou, RN – Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health

  Co-Author: Kelly Liepshutz, PA – Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc.

  Co-Author: Kayla Morgan, RN – Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health

  Co-Author: Anna Hostal, BS – Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health

  Co-Author: Meghna Bagchi, BS – Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health

  Co-Author: Leonid Serebryannyy, PhD – Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health

  Co-Author: Mike Castro, MS – Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health

  Co-Author: Michael Sibilo, MS – Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health

  Co-Author: Masaru Kanekiyo, PhD – Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health

  Co-Author: Lesia Dropulic, MD – Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health

  Co-Author: Kennichi Dowdell, PhD – Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health

  Co-Author: Wei Bu, PhD – Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health

  Co-Author: Jeffrey I Cohen, MD – Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health
• 2:33 PM - 2:45 PM US ET

  Incidence and Clinical Outcomes of RSV and Influenza in Solid Organ Transplant Recipients
  

  Presenting Author: Vivian Bui Le, MD (she/her/hers) – Centre of Excellence for Health, Immunity and Infections - CHIP, Copenhagen University Hospital, Rigshospitalet, Denmark

  Co-Author: Helene Høgsbro Thygesen, Biostatistician – Rigshospitalet

  Co-Author: Michael Perch, MD – University of Copenhagen

  Co-Author: Søren Scwartz Sørensen, Senior doctor – Rigshospitalet

  Co-Author: Kasper Rossing, Senior doctor – Rigshospitalet

  Co-Author: Nicolai Aagaard Schultz, Senior doctor – Rigshospitalet

  Co-Author: Jens Lundgren, MD DMSc – Rigshospitalet, University of Copenhagen

  Co-Author: Marie Helleberg, PhD, DMSc – Rigshospitalet, Copenhagen University Hospital
• 2:45 PM - 2:57 PM US ET

  Nirsevimab Binding Site Conservation in RSV F Protein between 2019 and 2024: Analysis of Sequencing Data from the US OUTSMART-RSV Surveillance Study and Public Databases
  

  Co-Author: Kelly Ann Mahool, PhD – AstraZeneca

  Co-Author: Gustavo H. Kijak, PharmD, PhD – AstraZeneca

  Co-Author: Bahar Ahani, BSC – AstraZeneca

  Co-Author: Tyler M. Brady, MPH – AstraZeneca

  Co-Author: Amy Nguyen, BSc – AstraZeneca

  Co-Author: Emma Schaefer, BSc – AstraZeneca

  Co-Author: Sarah R. Sincero, BSc (she/her/hers) – AstraZeneca

  Co-Author: Katie Streicher, PhD (she/her/hers) – AstraZeneca

  Co-Author: Kevin M. Tuffy, MS – AstraZeneca

  Presenting Author: Deidre Wilkins, BSC (she/her/hers) – Translational Medicine, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca